Trial
NCT00801931
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
—
Condition
Leukemia
Intervention
Alemtuzumab
Why stopped
Poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-03-27